Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-200x|57|4|572-577

ISSN： 1328-8067

Source： PEDIATRICS INTERNATIONAL, Vol.57, Iss.4, 2015-08, pp. : 572-577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event‐free survival in the NOPHO ALL92 protocol

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 4, 2014-04 ,pp. : 653-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 3, 2015-03 ,pp. : 261-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 4, 2014-10 ,pp. : 423-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 112-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 222-231

John Wiley & Sons Inc

Access to resources Recommend Favorite